Erlotinib as First-Line Treatment for Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Phase Iiib Study

Erlotinib as First-Line Treatment for Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Phase Iiib Study

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 26; p. i29
Main Authors: Zaric, B., Perin, B., Cekic, M., Rancic, M., Kovcin, V., Andric, Z., Murtezani, Z.H., Jovanovic, D., Velinovic, M., Markovic, M.
Format: Journal Article
Language:English
Published: 01-04-2015
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
DOI:10.1093/annonc/mdv050.22